Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Capital Expenditures (2019 - 2026)

Outset Medical has reported Capital Expenditures over the past 7 years, most recently at -$575000.0 for Q4 2025.

  • Quarterly Capital Expenditures rose 31.38% to -$575000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$263000.0 through Sep 2025, up 80.65% year-over-year, with the annual reading at $31000.0 for FY2024, 80.5% down from the prior year.
  • Capital Expenditures was -$575000.0 for Q4 2025 at Outset Medical, down from $474000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.9 million in Q4 2021 and troughed at -$2.9 million in Q3 2022.
  • The 5-year median for Capital Expenditures is $124500.0 (2021), against an average of $173250.0.
  • The largest YoY upside for Capital Expenditures was 341.48% in 2022 against a maximum downside of 2416.67% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $2.9 million in 2021, then crashed by 113.46% to -$389000.0 in 2022, then crashed by 472.75% to -$2.2 million in 2023, then soared by 62.39% to -$838000.0 in 2024, then soared by 31.38% to -$575000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Capital Expenditures are -$575000.0 (Q4 2025), $474000.0 (Q3 2025), and -$22000.0 (Q2 2025).